BioGenex and Abbott Molecular Conclude Successful PartnershipMarch 4, 2013
FREMONT, California, March 4, 2013 /PRNewswire/ -- After a long and successful collaboration and partnership, BioGenex and Abbott Molecular have announced that BioGenex will take over direct sales and support responsibility for co-branded Xmatrx instruments, auto FISH reagents and consumables, with immediate effect.
Xmatrx FISH, a product of successful partnership, enabled walk-away automation of all assay steps required to perform Abbott's FISH tests from baking to final cover slip, providing ready-to-view slides.
BioGenex will support current Xmatrx customers and enable their Xmatrx systems to perform other slide based assays to include IHC, ISH, SS, and miRNA, if desired. "Abbott and BioGenex are working closely and are committed to ensure seamless transition. Hospitals, labs, and research institutions that use Xmatrx can be assured that they will get best in class service and support. BioGenex and Abbott representatives have jointly advised the customers of this change. The transition to the next phase of our relationship is a testament to the truly unique capabilities of the Xmatrx platform, which allows automation of molecular pathology staining assays, from microtome to microscope," said Dr. Krishan Kalra, CEO, BioGenex.
About Xmatrx® ELITE
Xmatrx® ELITE is an integrated system consisting of a platform technology for full automation for any slide based assay in IHC, ISH, SS, miRNA & FISH. This truly all-in-one fully automated system maximizes testing capacity, minimizes hands-on time and ensures consistent and quality results every time. Xmatrx® ELITE, enabled with specially formulated and optimized reagents including primary antibodies, nucleic acid probes, special stains, detection kits and consumables delivers optimum performance while operating as a cost effective system. This underlies our commitment to provide flexible work flow solutions for today, tomorrow and beyond.
About us [www.biogenex.com]
BioGenex designs, develops and commercializes advanced and fully-automated Molecular Diagnostic Systems for cancer diagnosis, prognosis, therapy selection, personalized medicine, and life science research. Our products include fully automated instruments, Nucleic Acid probes, Antibodies, detection systems, ancillary reagents, and consumables to provide the total solution for ISH, CISH, IHC, SS, FISH, and in Situ PCR. Our customer focused approach, with premier after-sales support and excellent technical service, provides the best-in-class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest reagents and instruments for life Science research and diagnostics.